P2Y12 inhibitors plus aspirin versus aspirin alone in patients with minor stroke or high-risk transient ischemic attack
Background and purpose: We performed a systemic review and meta-analysis to elucidate
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …
[PDF][PDF] P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack
ZX Li, Y Xiong, HQ Gu, M Fisher, Y Xian, SC Johnston… - Stroke, 2021 - dickyricky.com
BACKGROUND AND PURPOSE: We performed a systemic review and meta-analysis to
elucidate the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 …
elucidate the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 …
[PDF][PDF] P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack
ZX Li, Y Xiong, HQ Gu, M Fisher, Y Xian, SC Johnston… - Stroke, 2021 - dickyricky.com
BACKGROUND AND PURPOSE: We performed a systemic review and meta-analysis to
elucidate the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 …
elucidate the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 …
P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack.
ZX Li, Y Xiong, HQ Gu, M Fisher, Y Xian, SC Johnston… - Stroke, 2021 - europepmc.org
Background and purpose We performed a systemic review and meta-analysis to elucidate
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …
P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack
ZX Li, Y Xiong, HQ Gu, M Fisher, Y Xian, SC Johnston… - Stroke, 2021 - Am Heart Assoc
BACKGROUND AND PURPOSE: We performed a systemic review and meta-analysis to
elucidate the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 …
elucidate the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 …
P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack
ZX Li, Y Xiong, HQ Gu, M Fisher, Y Xian… - …, 2021 - utsouthwestern.elsevierpure.com
Background and purpose: We performed a systemic review and meta-analysis to elucidate
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …
[PDF][PDF] P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack
ZX Li, Y Xiong, HQ Gu, M Fisher, Y Xian, SC Johnston… - Stroke, 2021 - 81.143.226.227
BACKGROUND AND PURPOSE: We performed a systemic review and meta-analysis to
elucidate the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 …
elucidate the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 …
P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack
ZX Li, Y Xiong, HQ Gu, M Fisher, Y Xian… - Stroke, 2021 - pubmed.ncbi.nlm.nih.gov
Background and purpose We performed a systemic review and meta-analysis to elucidate
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors …